Impaired myofibrillar function in the soleus muscle of mice with collagen-induced arthritis

Arthritis and Rheumatism

Volumn 60, Issue 11, 2009, Pages 3280-3289

  Yamada, Takashi ^a   Place, Nicolas ^a,b   Kosterina, Natalia ^c   Östberg, Therese ^a,d   Zhang, Shi Jin ^a   Grundtman, Cecilia ^a,d,e   Erlandsson Harris, Helena ^a,d   Lundberg, Ingrid E ^a,d   Glenmark, Birgitta ^f   Bruton, Joseph D ^a   Westerblad, Håkan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACTIN; CALCIUM ION; CARBONYL DERIVATIVE; COLLAGEN; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MUSCLE PROTEIN; MYOSIN HEAVY CHAIN; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; S NITROSOCYSTEINE; SUPEROXIDE DISMUTASE; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; IMMUNOBLOTTING; MOUSE; MUSCLE CONTRACTILITY; MUSCLE CONTRACTION; MUSCLE MASS; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLEUS MUSCLE; WESTERN BLOTTING;

ACTINS; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BODY WEIGHT; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED DBA; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MYOFIBRILS; MYOSIN HEAVY CHAINS; NITRIC OXIDE SYNTHASE; OXIDATION-REDUCTION; PEROXYNITROUS ACID; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 70350555329     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24907     Document Type: Article

References (50)

1. Sokka T, Hakkinen A, Kautiainen H, Maillefert JF, Tolaza S, Hansen J, et al. Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study. Arthritis Rheum 2008;59:42-50. (Pubitemid 351171877)
2. Lundberg IE, Nader GA. Molecular effects of exercise in patients with inflammatory rheumatic disease. Nat Clin Pract Rheumatol 2008;4:597-604.
3. Stenstrom CH, Minor MA. Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis. Arthritis Rheum 2003;49:428-434
4. Helliwell PS, Jackson S. Relationship between weakness and muscle wasting in rheumatoid arthritis. Ann Rheum Dis 1994;53:726-728 (Pubitemid 24347499)
5. Dalla Libera L, Ravara B, Gobbo V, Danieli Betto D, Germinario E, Angelini A, et al. Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol. J Mol Cell Cardiol 2005;38:803-807 (Pubitemid 40591745)
6. Szentesi P, Bekedam MA, van Beek-Harmsen BJ, van der Laarse WJ, Zaremba R, Boonstra A, et al. Depression of force production and ATPase activity in different types of human skeletal muscle fibers from patients with chronic heart failure. J Appl Physiol 2005;99:2189-2195 (Pubitemid 41691637)
7. Coirault C, Guellich A, Barbry T, Samuel JL, Riou B, Lecarpentier Y. Oxidative stress of myosin contributes to skeletal muscle dysfunction in rats with chronic heart failure. Am J Physiol 2007;292:H1009-17. (Pubitemid 46246952)
8. Lanone S, Mebazaa A, Heymes C, Henin D, Poderoso JJ, Panis Y, et al. Muscular contractile failure in septic patients: role of the inducible nitric oxide synthase pathway. Am J Respir Crit Care Med 2000;162:2308-2315 (Pubitemid 32051705)
9. Drew JS, Farkas GA, Pearson RD, Rochester DF. Effects of a chronic wasting infection on skeletal muscle size and contractile properties. J Appl Physiol 1988;64:460-465 (Pubitemid 18042268)
10. Supinski GS, Callahan LA. Free radical-mediated skeletal muscle dysfunction in inflammatory conditions. J Appl Physiol 2007;102:2056-2063
11. Ward CW, Reiken S, Marks AR, Marty I, Vassort G, Lacampagne A. Defects in ryanodine receptor calcium release in skeletal muscle from post-myocardial infarct rats. FASEB J 2003;17:1517-1519
12. Wehrens XH, Lehnart SE, Reiken S, van der Nagel R, Morales R, Sun J, et al. Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proc Natl Acad Sci U S A 2005;102:9607-9612 (Pubitemid 40981728)
13. Supinski G, Nethery D, Nosek TM, Callahan LA, Stofan D, DiMarco A. Endotoxin administration alters the force vs. pCa relationship of skeletal muscle fibers. Am J Physiol 2000;278:R891-6. (Pubitemid 30215201)
14. Yamada T, Mishima T, Sakamoto M, Sugiyama M, Matsunaga S, Wada M. Oxidation of myosin heavy chain and reduction in force production in hyperthyroid rat soleus. J Appl Physiol 2006;100:1520-1526
15. Szabo C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007;6:662-680 (Pubitemid 47207751)
16. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424. (Pubitemid 46217686)
17. Sandhu JK, Robertson S, Birnboim HC, Goldstein R. Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 2003;30:1173-1181 (Pubitemid 36666337)
18. Cuzzocrea S, McDonald MC, Mota-Filipe H, Mazzon E, Costantino G, Britti D, et al. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis. Arthritis Rheum 2000;43:320-328 (Pubitemid 30395740)
19. Supinski G, Stofan D, Callahan LA, Nethery D, Nosek TM, DiMarco A. Peroxynitrite induces contractile dysfunction and lipid peroxidation in the diaphragm. J Appl Physiol 1999;87:783-791 (Pubitemid 29375017)
20. Williams RO. Collagen-induced arthritis as a model for rheumatoid arthritis. Methods Mol Med 2004;98:207-216
21. Campbell IK, Hamilton JA, Wicks IP. Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 2000;30:1568-1575
22. Marinova-Mutafchieva L, Williams RO, Mason LJ, Mauri C, Feldmann M, Maini RN. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin Exp Immunol 1997;107:507-512 (Pubitemid 27102139)
23. Feldmann M, Brennan FM, Williams RO, Woody JN, Maini RN. The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2004;18:59-80. (Pubitemid 38324659)
24. Hardin BJ, Campbell KS, Smith JD, Arbogast S, Smith J, Moylan JS, et al. TNF-α acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle. J Appl Physiol 2008;104:694-699
25. Ekdahl C. Muscle function in rheumatoid arthritis: assessment and training. Scand J Rheumatol Suppl 1990;86:9-61. (Pubitemid 20294357)
26. Hakkinen A, Kautiainen H, Hannonen P, Ylinen J, Makinen H, Sokka T. Muscle strength, pain, and disease activity explain individual subdimensions of the Health Assessment Questionnaire disability index, especially in women with rheumatoid arthritis. Ann Rheum Dis 2006;65:30-34 (Pubitemid 41819020)
27. Kokkola R, Li J, Sundberg E, Aveberger AC, Palmblad K, Yang H, et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 2003;48:2052-2058 (Pubitemid 36828701)
28. Lannergren J. The force-velocity relation of isolated twitch and slow muscle fibres of Xenopus laevis. J Physiol 1978;283:501-521 (Pubitemid 9048125)
29. 2+] in single fibres from mouse limb muscles during repeated tetanic contractions. J Physiol 2003;551:179-190
30. Andrade FH, Reid MB, Allen DG, Westerblad H. Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibres from the mouse. J Physiol 1998;509:565-575 (Pubitemid 28287013)
31. Fagan JM, Sleczka BG, Sohar I. Quantitation of oxidative damage to tissue proteins. Int J Biochem Cell Biol 1999;31:751-757 (Pubitemid 29333119)
32. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254
33. Edman KA. The velocity of unloaded shortening and its relation to sarcomere length and isometric force in vertebrate muscle fibres. J Physiol 1979;291:143-159
34. Hennig R, Lomo T. Firing patterns of motor units in normal rats. Nature 1985;314:164-166 (Pubitemid 15137124)
35. Allen DG, Westerblad H. The effects of caffeine on intracellular calcium, force and the rate of relaxation of mouse skeletal muscle. J Physiol 1995;487:331-342
36. Ischiropoulos H, al-Mehdi AB. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett 1995;364:279-282
37. Ferreira LF, Reid MB. Muscle-derived ROS and thiol regulation in muscle fatigue. J Appl Physiol 2008;104:853-860
38. Alvarez B, Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids 2003;25:295-311. (Pubitemid 38041267)
39. Stamler JS, Sun QA, Hess DT. A SNO storm in skeletal muscle. Cell 2008;133:33-35
40. Allen DG, Lannergren J, Westerblad H. Muscle cell function during prolonged activity: cellular mechanisms of fatigue. Exp Physiol 1995;80:497-527.
41. Westerblad H, Allen DG. Changes of myoplasmic calcium concentration during fatigue in single mouse muscle fibers. J Gen Physiol 1991;98:615-635
42. Fryer MW, Neering IR. Actions of caffeine on fast- and slow-twitch muscles of the rat. J Physiol 1989;416:435-454 (Pubitemid 19223224)
43. El-Dwairi Q, Comtois A, Guo Y, Hussain SN. Endotoxin-induced skeletal muscle contractile dysfunction: contribution of nitric oxide synthases. Am J Physiol 1998;274:C770-9. (Pubitemid 28155618)
44. Tiago T, Simao S, Aureliano M, Martin-Romero FJ, Gutierrez-Merino C. Inhibition of skeletal muscle S1-myosin ATPase by peroxynitrite. Biochemistry 2006;45:3794-3804
45. Horwitz J, Bullard B, Mercola D. Interaction of troponin subunits: the interaction between the inhibitory and tropomyosin-binding subunits. J Biol Chem 1979;254:350-355
46. Perkins WJ, Han YS, Sieck GC. Skeletal muscle force and actomyosin ATPase activity reduced by nitric oxide donor. J Appl Physiol 1997;83:1326-1332
47. Barreiro E, Gea J, Corominas JM, Hussain SN. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2003;29:771-778 (Pubitemid 38045945)
48. Souza JM, Choi I, Chen Q, Weisse M, Daikhin E, Yudkoff M, et al. Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys 2000;380:360-366 (Pubitemid 30659107)
49. Nin N, Cassina A, Boggia J, Alfonso E, Botti H, Peluffo G, et al. Septic diaphragmatic dysfunction is prevented by Mn(III)porphyrin therapy and inducible nitric oxide synthase inhibition. Intensive Care Med 2004;30:2271-2278 (Pubitemid 40174266)
50. Mabley JG, Liaudet L, Pacher P, Southan GJ, Groves JT, Salzman AL, et al. Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Mol Med 2002;8:581-590 (Pubitemid 36337503)